US Patent Issued to Momenta Pharmaceuticals on Sept. 1 for "Anti-FcRn antibodies and methods for treating myasthenia gravis" (Pennsylvania, Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,087, issued on Sept. 1, was assigned to Momenta Pharmaceuticals Inc. (Titusville, N.J.).

"Anti-FcRn antibodies and methods for treating myasthenia gravis" was invented by Sindhu Ramchandren (Spring House, Pa.), Hong Sun (Spring House, Pa.), William Denney (Watertown, Mass.), Santiago Arroyo (Boston), Leona E. Ling (Spring House, Pa.), Jocelyn H. Leu (Spring House, Pa.), Jianhua Jin (Belmont, Mass.), Marie-Helene Jouvin (Jamaica Plain, Mass.), Keith Karcher (Titusville, N.J.), Shawn Black (Spring House, Pa.) and Yaowei Zhu (Wayne, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for dosing antibodies directed to human neonatal Fc receptor (...